Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RANOLAZINE STUDY: The Effect of Ranolazine on Speckle Tracking Derived Myocardial Strain in Regions of Non-Revascularizable Ischemic Myocardium

NCT03257683 is registered in ClinicalTrials.gov with Saint Thomas Health as lead sponsor.

NCT NCT03257683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03257683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RANOLAZINE STUDY: The Effect of Ranolazine on Speckle Tracking Derived Myocardial Strain in Regions of Non-Revascularizable Ischemic Myocardium
Lead sponsor
Saint Thomas Health
Phase
Observational
Overall status
Withdrawn
Start date
April 14, 2017
Completion date
February 16, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischaemic myocardial dysfunction, severe coronary artery disease